{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:07Z","timestamp":1760188987032},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[1990,9]]},"DOI":"10.1007\/bf02897290","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T20:21:01Z","timestamp":1209932461000},"page":"343-344","source":"Crossref","is-referenced-by-count":22,"title":["A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors"],"prefix":"10.1007","volume":"26","author":[{"given":"Peter C.","family":"Adamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Zimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel H.","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Balis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barton A.","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tresa J.","family":"Vietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Poplack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02897290_CR1","first-page":"41","volume":"36","author":"W Regelson","year":"1964","unstructured":"Regelson W, Holland JF, Frei E III, Gold GL, Hall TC, Krant M, Miller SO (1964) Comparative clinical toxicity of 6-mercaptopurine (NSC-755) and 6-mercaptopurine ribonucleoside (NSC-4911) administered intravenously to patients with advanced cancer. Cancer Chemother Rep 36: 41\u201348","journal-title":"Cancer Chemother Rep"},{"key":"BF02897290_CR2","first-page":"277","volume":"51","author":"W Regelson","year":"1967","unstructured":"Regelson W, Holland JF, Gold GL, Lynch J, Olson KB, Horton J, Hall TC, Krant M, Colsky J, Miller SP, Owens A (1967) 6-Mercaptopurine (NSC-755) given at weekly intervals to patients with advanced cancer. Cancer Chemother Rep 51: 277\u2013282","journal-title":"Cancer Chemother Rep"},{"key":"BF02897290_CR3","first-page":"738","volume":"34","author":"DM Tidd","year":"1974","unstructured":"Tidd DM, Paterson ARP (1974) A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 34: 738\u2013746","journal-title":"Cancer Res"},{"key":"BF02897290_CR4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM198304283081705","volume":"308","author":"S Zimm","year":"1983","unstructured":"Zimm S, Collins JM, Riccardi R, O\u2019Neill D, Narang PK, Chabner B, Poplack DG (1983) Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med 308: 1005\u20131009","journal-title":"N Engl J Med"},{"key":"BF02897290_CR5","first-page":"1869","volume":"45","author":"S Zimm","year":"1985","unstructured":"Zimm S, Ettinger LJ, Holcenberg JS, Kamen BA, Vitti TJ, Belasco J, Cogliano N, Balis FM, Lavi LE, Collins JM, Poplack DG (1985) Phase I and clinical pharmacological study of 6-mercaptopurine administered as a prolonged intravenous infusion. Cancer Res 45: 1869\u20131873","journal-title":"Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02897290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02897290\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02897290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T17:30:34Z","timestamp":1558546234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02897290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["BF02897290"],"URL":"https:\/\/doi.org\/10.1007\/bf02897290","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}